Page last updated: 2024-08-16

tropicamide and p-hydroxyamphetamine

tropicamide has been researched along with p-hydroxyamphetamine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19904 (50.00)18.7374
1990's4 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Charap, A; Cheetham, JK; Frank, J; Larkin, KM1
Applebaum, M; Jaanus, SD1
Molinari, JF1
Bartlett, JD; Semes, LP1
Appel, S; Appleman, W; Cooper, J; Feldman, JM; Horn, D; Jaanus, SD1
Bartlett, JD; Corliss, D; McDougall, BW; Mitten, L; Zeise, MM1
Gaynes, BI1
Anicho, UM; Cooper, J; Dignam, K; Feldman, J; Jaanus, SD1

Trials

3 trial(s) available for tropicamide and p-hydroxyamphetamine

ArticleYear
Ideal concentration of tropicamide with hydroxyamphetamine 1% for routine pupillary dilation.
    Annals of ophthalmology, 1989, Volume: 21, Issue:9

    Topics: Accommodation, Ocular; Adult; Amphetamines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Light; Male; p-Hydroxyamphetamine; Pupil; Pyridines; Random Allocation; Time Factors; Tropicamide

1989
Comparison of efficacy and tolerance between 1% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) and 0.5% tropicamide combined with 2.5% phenylephrine.
    Journal of the American Optometric Association, 1996, Volume: 67, Issue:11

    Topics: Accommodation, Ocular; Adult; Cross-Over Studies; Double-Blind Method; Drug Combinations; Eye Color; Female; Humans; Male; Mydriatics; Ophthalmic Solutions; p-Hydroxyamphetamine; Phenylephrine; Prospective Studies; Pupil; Tropicamide; Visual Acuity

1996
The clinical efficacy of paremyd with and without dapiprazole in subjects with light and dark brown irides.
    Optometry and vision science : official publication of the American Academy of Optometry, 1999, Volume: 76, Issue:2

    Topics: Accommodation, Ocular; Adolescent; Adrenergic alpha-Antagonists; Adult; Drug Therapy, Combination; Eye Color; Female; Glare; Humans; Iris; Male; Mydriatics; Ophthalmic Solutions; Ophthalmoscopy; p-Hydroxyamphetamine; Piperazines; Pupil; Triazoles; Tropicamide; Visual Acuity

1999

Other Studies

5 other study(ies) available for tropicamide and p-hydroxyamphetamine

ArticleYear
Use of diagnostic pharmaceutical agents and incidence of adverse effects.
    American journal of optometry and physiological optics, 1983, Volume: 60, Issue:5

    Topics: Adolescent; Adult; Aged; California; Child; Child, Preschool; Chlorobutanol; Cyclopentolate; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Edetic Acid; Eye; Female; Fluoresceins; Humans; Infant; Male; Middle Aged; Optometry; p-Hydroxyamphetamine; Phenylephrine; Povidone; Procaine; Propoxycaine; Registries; Tropicamide

1983
A clinical comparison of mydriatics.
    Journal of the American Optometric Association, 1983, Volume: 54, Issue:9

    Topics: Adult; Drug Administration Schedule; Female; Humans; Male; Mydriatics; Ophthalmoscopy; p-Hydroxyamphetamine; Pupil; Tropicamide

1983
Mydriatic effectiveness of hydroxyamphetamine.
    Journal of the American Optometric Association, 1982, Volume: 53, Issue:11

    Topics: Adult; Amphetamines; Drug Interactions; Female; Humans; Male; Mydriatics; p-Hydroxyamphetamine; Phenylephrine; Random Allocation; Reflex, Pupillary; Tropicamide

1982
Pupillary dilation and funduscopy with 1.0% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) versus tropicamide (0.5 or 1.0%) as a function of iris and skin pigmentation, and age.
    Journal of the American Optometric Association, 1996, Volume: 67, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Child; Child, Preschool; Drug Combinations; Eye Color; Female; Fundus Oculi; Humans; Male; Middle Aged; Mydriatics; Ophthalmoscopy; p-Hydroxyamphetamine; Pupil; Skin Pigmentation; Tropicamide

1996
Monitoring drug safety; cardiac events in routine mydriasis.
    Optometry and vision science : official publication of the American Academy of Optometry, 1998, Volume: 75, Issue:4

    Topics: Cardiovascular Diseases; Drug Combinations; Drug Monitoring; Eye Diseases; Heart; Humans; Mydriatics; p-Hydroxyamphetamine; Pupil; Safety; Tropicamide

1998